Treatment of glaucoma and ocular hypertension using rho kinase inhibitors: patent evaluation of US2018244666 and US2018256595

.

Source: Expert Opinion on Therapeutic Patents - August 22, 2019 Category: Drugs & Pharmacology Authors: Alessandro Bonardi Claudiu T Supuran Source Type: research